Spectrum and activity of three contemporary fluoroquinolones tested against Pseudomonas aeruginosa isolates from urinary tract infections in the SENTRY Antimicrobial Surveillance Program (Europe and the Americas; 2000): More alike than different!

Diagnostic Microbiology and Infectious Disease

Volumn 41, Issue 3, 2001, Pages 161-163

  Jones, Ronald N ^a,b   Beach, Mondell L ^a   Pfaller, Michael A ^c  

^a JMI LABORATORIES   (United States)

^b TUFTS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c UNIVERSITY OF IOWA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMIKACIN; AMINOGLYCOSIDE ANTIBIOTIC AGENT; CARBAPENEM; CEFEPIME; CIPROFLOXACIN; GATIFLOXACIN; GENTAMICIN; IMIPENEM; ISEPAMICIN; LEVOFLOXACIN; MEROPENEM; PIPERACILLIN; PIPERACILLIN PLUS TAZOBACTAM; QUINOLINE DERIVED ANTIINFECTIVE AGENT; TAZOBACTAM; TICARCILLIN; TOBRAMYCIN;

ANTIBIOTIC RESISTANCE; ANTIMICROBIAL ACTIVITY; ARTICLE; BACTERIUM ISOLATE; CONTROLLED STUDY; DRUG ACTIVITY; DRUG POTENCY; DRUG SENSITIVITY; EUROPE; GEOGRAPHIC DISTRIBUTION; HOSPITAL INFECTION; HUMAN; MINIMUM INHIBITORY CONCENTRATION; NONHUMAN; NORTH AMERICA; PRIORITY JOURNAL; PSEUDOMONAS AERUGINOSA; SOUTH AND CENTRAL AMERICA; SPECIES DIFFERENCE; STRAIN DIFFERENCE; URINARY TRACT INFECTION;

AMINOGLYCOSIDES; ANTI-BACTERIAL AGENTS; ANTI-INFECTIVE AGENTS; ANTI-INFECTIVE AGENTS, URINARY; CIPROFLOXACIN; DRUG RESISTANCE, BACTERIAL; EUROPE; FLUOROQUINOLONES; HUMANS; LACTAMS; LATIN AMERICA; MICROBIAL SENSITIVITY TESTS; NORTH AMERICA; OFLOXACIN; POPULATION SURVEILLANCE; PSEUDOMONAS AERUGINOSA; PSEUDOMONAS INFECTIONS; REGIONAL MEDICAL PROGRAMS; URINARY TRACT INFECTIONS;

EID: 0035679207     PISSN: 07328893     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0732-8893(01)00287-5     Document Type: Article

References (13)

1. Type II topoisomerase mutations in fluoroquinolone-resistant clinical strains of Pseudomonas aeruginosa isolated in 1998 and 1999: Role of target enzyme in mechanism of fluoroquinolone resistance
2. Activity and spectrum of 22 antimicrobial agents tested against urinary tract infection pathogens in hospitalized patients in Latin America: Report from the second year of the SENTRY Antimicrobial Surveillance Program (1998)
3. Characterization of Pseudomonas aeruginosa isolates: Occurrence rates, antimicrobial susceptibility patterns, and molecular typing in the Global SENTRY Antimicrobial Surveillance Program, 1997-1999
4. Antimicrobial resistance among uropathogens that cause community-acquired urinary tract infections in women: A nationwide analysis
5. Increasing prevalence of antimicrobial resistance among uropathogens causing acute uncomplicated cystitis in women
6. Susceptibility of Pseudomonas aeruginosa to fluoroquinolones: A year 2000 surveillance study, abstr. P29
7. Epidemiology and frequency of resistance among pathogens causing urinary tract infections in 1,510 hospitalized patients: A report from the SENTRY Antimicrobial Surveillance Program (North America)
8. System report: Data summary from October 1986 - April 1998, issued June 1998
9. Evaluation of current activities of fluoroquinolones against Gram-negative bacilli using centralized in vitro testing and electronic surveillance
10. Detection of gyr A mutations among 335 Pseudomonas aeruginosa strains isolated in Japan and their susceptibilities to fluoroquinolones
11. Guidelines for antimicrobial treatment of uncomplicated acute bacterial cystitis and acute phelonephritis in women